Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insulin-like growth factor-I and its binding protein-3 in serum: are they good screening properties for the diagnosis of growth hormone deficiency?

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies - 1 May 1997

Koch A, Dörr H G

Abstract excerpt

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are simply-determined screening analytes if growth hormone deficiency is suspected. The analysis of growth hormone secretion using standardised stimulation tests and secretion profiles is complicated and expensive in comparison. In retrospect, we have examined the value of insulin-like growth factor-I and its binding protein-3 for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Body Height

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Genetic Variation

Share to Growth Disorders

Share to Insulin-Like Growth Factor I

Share to Predictive Value of Tests

Source

Identifiers

PMID: 9189743
DOI: 10.1515/cclm.1997.35.5.379

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insulin-like growth factor-I and its binding protein-3 in serum: are they good screening properties for the diagnosis of growth hormone deficiency?PMID 9189743Read ↗

National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.Semantic proximity Read ↗

Efficacy and safety of growth hormone therapy in children with Noonan syndrome.Semantic proximity Read ↗

The GH-IGF-I axis in children with idiopathic short stature.Semantic proximity Read ↗

Partial growth hormone deficiency in adults; should we be looking for it?Semantic proximity Read ↗

Growth hormone insensitivity syndromes: lessons learned and opportunities missed.Semantic proximity Read ↗

Growth hormone insensitivity: diagnostic and therapeutic approachesSemantic proximity Read ↗

Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised? .Semantic proximity Read ↗

Diagnostic and therapeutic advances in growth hormone insensitivity.Semantic proximity Read ↗

Challenges of insulin-like growth factor-1 testingSemantic proximity Read ↗

Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.Semantic proximity Read ↗

Quantification of the GH/IGF-axis components: Lessons from human studiesSemantic proximity Read ↗

Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.